Desq Long
Sign in
SEC FORM 4
—

Monopar Therapeutics (MNPR)

Acquisition (code M) of 9,801 shares; price not stated (see filing).

Reporting Person Robinson Chandler · Officer Title Chief Executive Officer · Transaction Code M

Traded Sep 30, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001437749-26-031925 · filed 2026-10-02 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Monopar Therapeutics (MNPR)." Disclosed 2026-10-02. https://desqlong.com/cards/0001437749-26-031925-1 (retrieved 2026-10-03).